Cochrane Abstracts
Intratympanic gentamicin for Ménière's disease or syndrome
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Intratympanic Gentamicin for Ménière's Disease or Syndrome." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/431861/all/Intratympanic_gentamicin_for_Ménière's_disease_or_syndrome.
Intratympanic gentamicin for Ménière's disease or syndrome. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431861/all/Intratympanic_gentamicin_for_Ménière's_disease_or_syndrome. Accessed January 30, 2025.
Intratympanic gentamicin for Ménière's disease or syndrome. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431861/all/Intratympanic_gentamicin_for_Ménière's_disease_or_syndrome
Intratympanic Gentamicin for Ménière's Disease or Syndrome [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 January 30]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/431861/all/Intratympanic_gentamicin_for_Ménière's_disease_or_syndrome.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Intratympanic gentamicin for Ménière's disease or syndrome
ID - 431861
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/431861/all/Intratympanic_gentamicin_for_Ménière's_disease_or_syndrome
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
